The clinical potential of adipogenesis and obesity-related microRNAs

被引:71
|
作者
Zaiou, M. [1 ]
El Amri, H. [2 ]
Bakillah, A. [3 ]
机构
[1] Univ Lorraine, Fac Pharm, 5 Rue Albert Lebrun, F-54000 Nancy, France
[2] Lab Genet Gendarmerie Royale, Ave Ibn Sina, Rabat, Morocco
[3] Suny Downstate Med Ctr, Dept Med, 450 Clarkson Ave, Brooklyn, NY 11203 USA
关键词
Adipogenesis; Biomarkers; Metabolic disease; microRNAs; Obesity; Type 2 diabetes mellitus; MESENCHYMAL STEM-CELLS; ACTIVATED-RECEPTOR-GAMMA; BROWN ADIPOSE-TISSUE; HUMAN ADIPOCYTE DIFFERENTIATION; NOTCH SIGNALING PROMOTES; CIRCULATING MICRORNAS; INSULIN-RESISTANCE; GENE-EXPRESSION; PPAR-GAMMA; BEIGE FAT;
D O I
10.1016/j.numecd.2017.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a growing health problem commonly associated with numerous metabolic disorders including type 2 diabetes, hypertension, cardiovascular disease, and some forms of cancer. The burden of obesity and associated cardiometabolic diseases are believed to arise through complex interplay between genetics and epigenetics predisposition, nutrition, environment, and lifestyle. However, the molecular basis and the repertoire of obesity-affecting factors are still unknown. Emerging evidence is connecting microRNAs (miRNAs) dysregulation with adipogenesis and obesity. Alteration in miRNAs expression could result in changes in the pattern of genes controlling a range of biological processes including inflammation, lipid metabolism, insulin resistance and adipogenesis. Hence, understanding exact roles of miRNAs as well as the degree of their contribution to the regulation of adipogenesis and fat cell development in obesity would provide new therapeutic targets for the development of novel and effective anti-obesity drugs. The objective of the current review is to: (i) discuss some of the latest development on relevant miRNAs dysregulation mainly in human adipogenesis and obesity, (ii) emphasize the role of circulating miRNAs as new promising therapeutics and attractive potential biomarkers for treating obesity and associated risk factor diseases, (iii) describe how dietary factors may influence obesity through modulation of miRNAs expression, (iv) highlight some of the actual limitations to the promise of miRNAs as novel therapeutics as well as to their translation for the benefit of patients, and finally (v) provide recommendations for future research on miRNA-based therapeutics that could lead to a breakthrough in the treatment of obesity and its associated pathologies. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 111
页数:21
相关论文
共 50 条
  • [1] Role of microRNAs in obesity and obesity-related diseases
    Iacomino, Giuseppe
    Siani, Alfonso
    [J]. GENES AND NUTRITION, 2017, 12
  • [2] Role of microRNAs in obesity and obesity-related diseases
    Giuseppe Iacomino
    Alfonso Siani
    [J]. Genes & Nutrition, 2017, 12
  • [3] Depot- and obesity-related differences in adipogenesis
    Lessard, Julie
    Tchernof, Andre
    [J]. CLINICAL LIPIDOLOGY, 2012, 7 (05) : 587 - 596
  • [4] Role of microRNAs in Obesity-Related Kidney Disease
    Caus, Maite
    Eritja, Auria
    Bozic, Milica
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [5] Role of MicroRNAs in Dietary Interventions for Obesity and Obesity-Related Diseases
    Zhang, Ji-Yue
    Ren, Chao-Qin
    Cao, Ya-Nan
    Ren, Yuanhang
    Zou, Liang
    Zhou, Chuang
    Peng, Lian-Xin
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (40) : 14396 - 14412
  • [6] microRNAs in the Regulation of Adipogenesis and Obesity
    McGregor, R. A.
    Choi, M. S.
    [J]. CURRENT MOLECULAR MEDICINE, 2011, 11 (04) : 304 - 316
  • [7] Obesity-Related Glomerulopathy: Clinical Management
    Herman-Edelstein, Michal
    Weinstein, Talia
    Chagnac, Avry
    [J]. SEMINARS IN NEPHROLOGY, 2021, 41 (04) : 358 - 370
  • [8] MicroRNAs in adipogenesis and as therapeutic targets for obesity
    Alexander, Ryan
    Lodish, Harvey
    Sun, Lei
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 623 - 636
  • [9] The clinical potential of circulating microRNAs in obesity
    Chenbo Ji
    Xirong Guo
    [J]. Nature Reviews Endocrinology, 2019, 15 : 731 - 743
  • [10] MicroRNAs: Emerging roles in adipogenesis and obesity
    Peng, Yongdong
    Yu, Shulong
    Li, Huanan
    Xiang, Hong
    Peng, Jian
    Jiang, Siwen
    [J]. CELLULAR SIGNALLING, 2014, 26 (09) : 1888 - 1896